We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is... PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. Show more
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results PR Newswire WARREN, N.J., April 25, 2024 β Strong revenue performance across product portfolio β β...
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire WARREN, N.J., April 23, 2024 WARREN, N.J., April 23, 2024 /PRNewswire/ -- PTC Therapeutics, Inc...
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results PR Newswire SOUTH PLAINFIELD, N.J., April 11, 2024 SOUTH PLAINFIELD, N.J., April 11, 2024 /PRNewswire/...
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA PR Newswire SOUTH PLAINFIELD, N.J., March 28, 2024 - First marketing authorization submission for sepiapterin with...
PTC Therapeutics Provides Key Regulatory Updates PR Newswire SOUTH PLAINFIELD, N.J., March 19, 2024 -Β BLA submitted to FDA for Upstazaβ’ for the treatment of AADC deficiency - -Β NDA to be...
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire SOUTH PLAINFIELD, N.J., Feb. 29, 2024 β 34% year-over-year growth in 2023...
PTC Therapeutics to Participate at Upcoming Investor Conferences PR Newswire SOUTH PLAINFIELD, N.J., Feb. 27, 2024 SOUTH PLAINFIELD, N.J., Feb. 27, 2024 /PRNewswire/ -- PTC Therapeutics, Inc...
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH PLAINFIELD, N.J., Feb. 22, 2024 SOUTHΒ PLAINFIELD, N.J., Feb. 22, 2024 /PRNewswire/ -- PTC...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.69 | 19.5335276968 | 24.01 | 29.27 | 23.995 | 1383879 | 25.40690032 | CS |
4 | -0.31 | -1.06859703551 | 29.01 | 29.42 | 23.995 | 847154 | 26.21667817 | CS |
12 | 3.13 | 12.2409073133 | 25.57 | 32.905 | 23.58 | 867264 | 27.62291829 | CS |
26 | 5.24 | 22.3358908781 | 23.46 | 32.905 | 17.53 | 1065238 | 25.66331844 | CS |
52 | -22.5 | -43.9453125 | 51.2 | 59.84 | 17.53 | 1040847 | 30.54046406 | CS |
156 | -17.46 | -37.8249566724 | 46.16 | 59.84 | 17.53 | 762683 | 36.56025608 | CS |
260 | -9.95 | -25.74385511 | 38.65 | 70.82 | 17.53 | 718707 | 40.94055047 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions